About OJO | Search | Ahead of print | Current Issue | Archives | Author Instructions | Reviewer Guidelines | Online submissionLogin 
Oman Journal of Ophthalmology Oman Journal of Ophthalmology
  Editorial Board | Subscribe | Advertise | Contact
https://www.omanophthalmicsociety.org/ Users Online: 811  Wide layoutNarrow layoutFull screen layout Home Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study

Azad Rajvardhan, Sain Siddarth, Sharma Yog Raj, Mahajan Deepankur

Year : 2012| Volume: 5| Issue : 3 | Page no: 166-170

   This article has been cited by
 
1 Intravitreal steroids for macular edema in diabetes
Thanitsara Rittiphairoj, Tahreem A Mir, Tianjing Li, Gianni Virgili
Cochrane Database of Systematic Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications
Oluwaranti Akiyode, Christine Tran
Diabetes Spectrum. 2016; 29(1): 44
[Pubmed]  [Google Scholar] [DOI]
3 Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: A meta-analysis
Zhang, X.-L., Chen, J., Zhang, R.-J., Zhou, Q., Qin, X.-Y.
International Journal of Ophthalmology. 2013; 6(4): 546-552
[Pubmed]  [Google Scholar]

 

Read this article